A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms | MicrobiomeTrials← Back to trialsNCT07469891
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-04-29Est. Completion: 2028-04
Enrollment target: 100 participants Locations- Colorado Blood Cancer Institute, Denver, Colorado, United States
- BRCR Global - Coral Springs, Coral Springs, Florida, United States
- START Midwest, LLC, Grand Rapids, Michigan, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office, Philadelphia, Pennsylvania, United States
- Tristar BMT, Nashville, Tennessee, United States
Other microbiome trials you might be interested in
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
This is a phase II, open label, prospective, single-arm study evaluating the efficacy and safety of selinexor in patient…
Salt Lake City, United StatesCompleted Aug 16, 2023
Polycythemia Vera
The purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of car…
Miami, United StatesEst. completion Sep 2028